ASCO 2025 Signals a New Chapter in Myelofibrosis Care The 2025 ASCO Annual Meeting delivered early insights into the future of myelofibrosis (MF) treatments. For Clinical Services International (CSI), a trusted sourcing partner for global oncology trials, this represents a significant scientific milestone. What’s New in MF and Why It Matters JAK inhibitors continue to be foundational in MF treatment, with ruxolitinib remaining a strong first-line option. However, ASCO 2025 hi

Earlier this month, the US President signed a landmark executive order aimed at delivering “most favored nation” (MFN) pricing for...

We’re incredibly proud to announce that CSI has once again achieved the Platinum EcoVadis rating, for the second year in a row! This places us in the top 1% globally for sustainability, ethics and corporate responsibility. It’s an incredible accomplishment and a testament to the values we live by every day. A huge thank you to our dedicated team for making this possible, your commitment continues to set us apart.

In clinical trials, every element of the supply chain matters. From sourcing high-quality comparator drugs to managing timelines across borders, sponsors often ask: which is the bigger challenge, drug sourcing or the logistics that follow? At Clinical Services International (CSI), we believe the answer isn’t either/or. It’s how you manage both that determines trial success. Comparator Sourcing: A Global Jigsaw Puzzle Sourcing comparator drugs can be a significant challenge, p

Request A global listed Biotech company required large quantities of Eylea Pre-Filled Syringes (PFS) sourced across both the EU and USA. Their priorities included: Relatively Stable pricing over a 2-3 year period Best possible expiry dates to accommodate packaging timelines (losing 6-8 weeks in the process) Ensuring continuous supply by replenishing stock before expiry (~14-16 months) Bulk procurement in single large batches for efficiency in regular intervals Challenges Ma

So are we! We’re pleased to share that Jonathan Miller, CSI’s Head of Operations, North America, will be attending Jefferies New York 2025 this June. If you’re a pharmaceutical or biotech company with comparator drugs in your pipeline, from early planning to on-demand global delivery, Jonathan would be happy to connect. Clinical Services International specializes in supporting complex, high-value clinical trials across all therapeutic areas. 📅 Let’s set up a meeting to explo

Client Request A leading global biopharmaceutical company approached CSI with an urgent need for the Fluarix QIV Southern Hemisphere Vaccine 2025. The requirements included: Quantity: 10,000 doses Delivery Date: As soon as possible (urgent) Delivery Location: Singapore Batch Preference: Multiple lots acceptable if necessary The Challenge The client was let down by a supplier in Brazil and needed to secure alternative stock at the last minute. Complicating matters, the Fluarix

CSI’s Strategic Approach to Mitigating Clinical Trial Supply Disruption Recent developments in U.S. trade policy are shaking up supply chains, not just within the United States but worldwide. With the re-introduction of Trump-era tariffs on key goods, companies engaged in clinical research must rethink their sourcing and logistics strategies. Clinical Services International (CSI) is proactively addressing these challenges to support our clients amid this uncertain climate. Wh

We’re proud to share that CSI is now fully registered and qualified with SAM.gov and BARDA , enabling us to support U.S....

A Global Pharmaceutical Sponsor’s Challenge A global pharmaceutical sponsor conducting a Phase III clinical trial needed Semaglutide, a GLP-1 receptor agonist, as a comparator drug. The study spanned multiple regions, including North America, Europe, and Asia-Pacific. This required a consistent and compliant supply of the drug across various regulatory landscapes. The sponsor needed a reliable partner to source Semaglutide efficiently while ensuring batch consistency, Certifi

CSI attended the Global Clinical Supplies Group (GCSG) US Conference in San Antonio, Texas, April 27th-30th. The event brought together clinical supply professionals from around the world to discuss industry trends, challenges and strategies for your clinical trial pipeline. CSI’s Managing Director, Vanessa Dekou, hosted a successful and sell-out workshop at GCSG US, to share over 25 years’ worth of expert insights on the complexities of comparator sourcing strategies. If yo